Stevanato Group S.p.A. Q4 2025 Earnings Call Summary

Moby summary of Stevanato Group S.p.A.'s Q4 2025 earnings call ...
Business Wire

Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...